GlaxoSmithKline I+D, S.L.
Tres Cantos, Madrid, Comunidad de, Spain
Purpose
to establish a portfolio of small molecule hits, leads and clinical assets against drug-resistant shigellosis and other enteric bacterial pathogens
Division
Global Health
Date
April 2017
Region Served
GLOBAL
Committed amount
$659,802
Grant topic
Discovery and Translational Sciences
Duration (months)
38
Grantee location
Tres Cantos, Madrid, Comunidad de, Spain
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.